PR Newswire - Pennsylvania

		InfoLogix logo. (PRNewsFoto/InfoLogix, Inc.) HATBORO, PA UNITED STATES

	    HATBORO, Pa., Nov. 10 /PRNewswire-FirstCall/ -- InfoLogix, Inc.
(Nasdaq: IFLG), a leading technology provider of enterprise mobility
solutions for the healthcare and commercial industries, today announced
that NASDAQ has granted the Company's request for an exception to NASDAQ's
stockholder approval requirements, in accordance with NASDAQ Listing Rule
5635(f). The Company is relying on this exception to complete a proposed
plan of restructuring, pursuant to which a portion of the Company's
outstanding debt with Hercules Technology Growth Capital, Inc. (Nasdaq:
HTGC), ("Hercules") would be converted into equity in the Company, the
remaining outstanding debt with Hercules would be otherwise restructured,
the Company would issue warrants to Hercules or its affiliate to purchase
equity in the Company, and certain other debt and earnout obligations with
other parties would be restructured. The Company currently anticipates that
the transaction would close on or about November 20, 2009. The
restructuring would result in cancellation of $5 million in indebtedness
and provide for up to $5 million in availability under a revolving credit
facility with Hercules.

    (Logo: http://www.newscom.com/cgi-bin/prnh/20090618/NE35135LOGO )

    Under the proposed plan of restructuring, Hercules or one of its
affiliates would exchange $5 million in indebtedness for 67,294,751 shares
of the Company's common stock and a warrant to purchase 16,823,688 shares
of the Company's common stock at an exercise price of $0.0743 per share.
The Company would agree to register these shares with the Securities and
Exchange Commission for resale.

    The remainder of the Company's indebtedness with Hercules would be
restructured to include two term loans aggregating $10.5 million and a
revolving credit facility of $12 million, of which $7 million would be
deemed drawn immediately following the closing of the restructuring. The
revolving credit facility would expire in May 2011, but would be extended
for six months under certain circumstances. Any borrowings under the
revolving line of credit facility would bear interest initially at 12.0%
per annum until such time that the term loans are repaid, when the interest
rate on outstanding borrowings would be prime plus 4%. Borrowings under the
credit facility would be based on eligible accounts receivable, including
an over advance provision of up to $500,000, which would be due four weeks
after the over advance is drawn. Over advances would bear interest at 15%
per annum.

    The term loans would include a $5.5 million ("Term Loan A") 48-month
amortizing loan and a $5 million ("Term Loan B") convertible note due in
November 2014. Amortization on Term Loan A would begin on December 1, 2010.
Term Loan B would be convertible into shares of the Company's common stock
at Hercules' option, or automatically if the 90-day value weighted adjusted
price of the Company's common stock exceeds five times the conversion
price. The conversion price of Term Loan B is $0.0743. The outstanding
principal balances on both term loans would bear interest at 12% per annum
for the initial twelve months; 18% per annum for the subsequent twelve
months and 15% per annum thereafter. This interest would be payable in
cash. Term Loan B would bear an additional 2.5% interest that would be
"paid in kind" ("PIK"). The Company would have the option to turn the PIK
interest into cash interest or additional shares of common stock if certain
predefined metrics are maintained. Each term loan would be assessed a
prepayment charge beginning at 5% of the total term loan commitment, and
reduced to 3% after twelve months and to 1% after two years.

    The restructuring has certain negative and financial covenants and
other stipulations associated with the arrangement. The Company would also
be assessed a transaction fee equal of $450,000. Following the transaction,
Hercules or its affiliate would own approximately 55% of the Company on a
fully diluted basis.

    Absent this exception, NASDAQ rules would have required the approval of
the Company's stockholders prior to the issuance of equity capital to
Hercules or its affiliate. To obtain this exception, the Company was
required to demonstrate to NASDAQ that the delay associated with the effort
to secure stockholder approval prior to consummation of the transaction
would have seriously jeopardized the Company's financial viability. As also
required by NASDAQ, on October 9, 2009, the Audit Committee of the
Company's Board of Directors expressly approved the Company's reliance on
this exception.

    In addition to the foregoing, on October 30, 2009, the Company received
notice that the NASDAQ Listing Qualifications Staff has granted the
Company's request for an extension to regain compliance with the listing
rules of the NASDAQ Capital Market. The notice is in response to a letter
received from NASDAQ notifying the Company that it was not in compliance
with the continued listing rules of the NASDAQ Capital Market because the
Company did not meet the requirement to have at least $2.5 million in
stockholders' equity as set forth in NASDAQ Listing Rule 5550(b)(1). The
Company's continued listing on NASDAQ is subject to the condition that the
Company evidence compliance with the stockholders' equity requirement by no
later than November 20, 2009. The Staff's determination follows the
Company's previous disclosure on August 21, 2009, regarding its
non-compliance with the minimum stockholders' equity requirement.

    While the Company believes it can satisfy the terms of the Staff's
determination, there can be no assurance that the Company will do so. If
the Company does not, the Company may request a hearing before the NASDAQ
Listing Qualifications Panel. Such request would stay any delisting
determination by the Staff and the Company's securities would remain listed
on NASDAQ pending a formal determination by the Panel.

    About InfoLogix, Inc.

    InfoLogix is a leading provider of enterprise mobility solutions for
the healthcare and commercial industries. InfoLogix uses the industry's
most advanced technologies to increase the efficiency, accuracy, and
transparency of complex business and clinical processes. With 19 issued
patents, InfoLogix provides mobile managed solutions, on-demand software
applications, mobile infrastructure products, and strategic consulting
services to over 2,000 clients in North America including Kraft Foods,
Merck and Company, General Electric, Kaiser Permanente, MultiCare Health
System and Stanford School of Medicine. InfoLogix is a publicly-traded
company (Nasdaq: IFLG). For more information visit http://www.infologix.com.

    Safe Harbor

    InfoLogix makes forward-looking statements, including those relating to
debt restructuring and continued listing on Nasdaq, in this press release
which represent our expectations or beliefs about future events and
financial performance. Forward-looking statements are identifiable by words
such as "believe," "anticipate," "expect," "intend," "plan," "will," "may"
and other similar expressions. In addition, any statements that refer to
expectations, projections or other characterizations of future events or
circumstances are forward-looking statements. Forward-looking statements
are subject to known and unknown risks and uncertainties, including the
risks described in our Annual Report on Form 10-K for the period ended
December 31, 2008, our Quarterly Report on Form 10-Q for the period ended
June 30, 2009 and other filings we make with the Securities and Exchange
Commission. In addition, actual results could differ materially from those
suggested by the forward-looking statements, and therefore you should not
place undue reliance on the forward-looking statements. We do not make any
commitment to revise or update any forward-looking statements to reflect
events or circumstances occurring or existing after the date of any
forward-looking statement is made.



    Contact:
    John A. Roberts
    Chief Financial Officer
    215-604-0691 x1102